Torthaí cuardaigh - Martin Gramatzki

Beachtaigh na torthaí
  1. 1
    Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor

    Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor de réir Roland Repp, Thomas Valerius, A. Sendler, Martin Gramatzki, Heinrich Iro, JR Kalden, E Platzer

    Foilsithe / Cruthaithe 1991
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Human Herpesvirus Type 8 Interleukin-6 Homologue Is Functionally Active on Human Myeloma Cells

    Human Herpesvirus Type 8 Interleukin-6 Homologue Is Functionally Active on Human Myeloma Cells de réir Renate Burger, Frank Neipel, Bernhard Fleckenstein, Rocco Savino, Gennaro Ciliberto, Joachim R. Kalden, Martin Gramatzki

    Foilsithe / Cruthaithe 1998
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy de réir Thomas Valerius, Roland Repp, TP de Wit, Berthold Seitz, E Platzer, JR Kalden, Martin Gramatzki, JG van de Winkel

    Foilsithe / Cruthaithe 1993
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

    CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia de réir Naoki Hosen, Christopher Y. Park, Naoya Tatsumi, Yusuke Oji, Haruo Sugiyama, Martin Gramatzki, Alan M. Krensky, Irving L. Weissman

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells

    Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells de réir Hans‐Heinrich Oberg, Christian Kellner, Daniel Gonnermann, Susanne Sebens, Dirk Bauerschlag, Martin Gramatzki, Dieter Kabelitz, Matthias Peipp, Daniela Wesch

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy

    Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy de réir Thomas Valerius, Roland Repp, TP de Wit, Berthold Seitz, E Platzer, JR Kalden, Martin Gramatzki, JG van de Winkel

    Foilsithe / Cruthaithe 1993
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

    Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing de réir Michael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, Roland Repp, Martin J. Glennie, Martin Gramatzki, Jan G. J. van de Winkel, Thomas Valerius

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation

    Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation de réir Katja Brocke-Heidrich, A. Kretzschmar, Gabriele Pfeifer, Christian Henze, Dennis Löffler, Dirk Koczan, Hans‐Jürgen Thiesen, Renate Burger, Martin Gramatzki, Friedemann Horn

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    The bisphosphonate zoledronic acid has antimyeloma activity <i>in vivo</i> by inhibition of protein prenylation

    The bisphosphonate zoledronic acid has antimyeloma activity <i>in vivo</i> by inhibition of protein prenylation de réir Andreas Guenther, Sharon Gordon, Markus Tiemann, Renate Burger, Frank Bakker, Jonathan R. Green, Wolfgang Baum, Anke J. Roelofs, Michael J. Rogers, Martin Gramatzki

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor

    HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor de réir David Elsässer, Thomas Valerius, Roland Repp, George J. Weiner, Yashwant M. Deo, JR Kalden, JG van de Winkel, GT Stevenson, MJ Glennie, Martin Gramatzki

    Foilsithe / Cruthaithe 1996
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Phase II trial of zanolimumab (HuMax‐CD4) in relapsed or refractory non‐cutaneous peripheral T cell lymphoma

    Phase II trial of zanolimumab (HuMax‐CD4) in relapsed or refractory non‐cutaneous peripheral T cell lymphoma de réir Francesco d’Amore, John Radford, Thomas Relander, Mats Jerkeman, Hervé Tilly, Anders Österborg, Franck Morschhauser, Martin Gramatzki, Martin Dreyling, B K Bang, Hans Hagberg

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial

    IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial de réir Jens Atzpodien, Hartmut Kirchner, H.J. Illiger, Bernd Metzner, D. Ukena, Harold C. Schott, P.-J. Funke, Martin Gramatzki, S von Jürgenson, T Wandert, T Patzelt, Martina Reitz

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity

    Mimicking an Induced Self Phenotype by Coating Lymphomas with the NKp30 Ligand B7-H6 Promotes NK Cell Cytotoxicity de réir Christian Kellner, Tina Maurer, Daniela Hallack, Roland Repp, Jan G. J. van de Winkel, Paul W.H.I. Parren, Thomas Valerius, Andreas Humpe, Martin Gramatzki, Matthias Peipp

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT

    Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT de réir Avichai Shimoni, Myriam Labopin, Jürgen Finke, Fabio Ciceri, Éric Deconinck, Nicolaus Kröger, Martin Gramatzki, Matthias Stelljes, Didier Blaise, Friedrich Stoelzel, Patrice Chevallier, Ernst Holler, Nathalie Fegueux, Mohamad Mohty, Arnon Nagler

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

    Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer de réir Dennis Löffler, Katja Brocke-Heidrich, Gabriele Pfeifer, Claudia Stocsits, Jörg Hackermüller, A. Kretzschmar, Renate Burger, Martin Gramatzki, Conny Blumert, Kay Bauer, Helena Cvijic, A. Kerstin Ullmann, Peter F. Stadler, Friedemann Horn

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working P... de réir Anna Sureda, Stephen Robinson, Carmen Canals, Angelo Michele Carella, Marc Boogaerts, Dolores Caballero, Ann E. Hunter, Lothar Kanz, Shimon Slavin, Jan J. Cornelissen, Martin Gramatzki, Dietger Niederwieser, Nigel H. Russell, Norbert Schmitz

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

    Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II stud... de réir Wolfram Brugger, Joy Hirsch, Frank Grünebach, Roland Repp, Peter Brossart, Wichard Vogel, Hans‐Georg Kopp, Markus G. Manz, Michael Bitzer, Günter Schlimok, Martin Kaufmann, Arnold Ganser, K. Fehnle, Martin Gramatzki, Lothar Kanz

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy

    Triggering FCα-Receptor I (CD89) Recruits Neutrophils as Effector Cells for CD20-Directed Antibody Therapy de réir Bernhard Stockmeyer, Michael Dechant, Marjolein van Egmond, Alison L. Tutt, Karuna Sundarapandiyan, Robert F. Graziano, Roland Repp, Joachim R. Kalden, Martin Gramatzki, Martin J. Glennie, Jan G. J. van de Winkel, Thomas Valerius

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells

    Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells de réir Hans‐Heinrich Oberg, Matthias Peipp, Christian Kellner, Susanne Sebens, Sarah Krause, Domantas Petrick, Sabine Adam‐Klages, Christoph Röcken, Thomas Becker, Ilka Vogel, D. Weisner, Sandra Freitag‐Wolf, Martin Gramatzki, Dieter Kabelitz, Daniela Wesch

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial

    Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial de réir Thomas Elter, Peter Borchmann, H. Schulz, Marcel Reiser, Sven Trelle, Roland Schnell, Markus Jensen, Peter Staib, Timo Schinköthe, H. Stützer, Jürgen Rech, Martin Gramatzki, Walter E. Aulitzky, Ibrahim Hasan, Andreas Josting, Michael Hallek, Andreas Engert

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: